<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200410047011N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-30</date_registration>
      <primary_sponsor>Artesh University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effectiveness of different modes of position change on the effects of sheet removal after femoral angiography</public_title>
      <acronym></acronym>
      <scientific_title>Comparison on effectiveness of different methods of changing position on side effects of sheet removal after femoral angiography in patients  referring to hospital</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47039</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 72 patients will be selected based on the criteria for entering the study and based on the target method and will be assigned to two test and control groups (36 people in each group) by simple random method. In this way, the patients will be placed in two groups of test and control based on the coin toss on the couple and individual days of the week.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Femoral angiography in cardiovascular patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: patients will be cared for in the first hour after angiography, lying down and keeping their legs still. In the second hour with a flat angle of 15 degrees, in the third hour they will be in a semi-sitting position with an angle of 30 degrees and in the fourth hour onwards with a 45 degree angle of the bed. It should be noted that at all stages of the intervention, the sandbag will be placed on the dressing area of ​​the arterial access site and the patients' feet will be flat. From the third hour onward, a pillow will be placed in the patient's lumbar region for more comfort. In case of bleeding, pain and dissatisfaction, the patient will return to the supine position and will be pressed 5 cm above the dressing area by hand. It remains and the routine treatment protocol continues. It is important to note that all patients prophylactically use anticoagulants such as aspirin 80 mg and Plavix 300 mg single dose for angiography as directed by their physician. Intervention 2: Control group: In control group patients, routine post-angiographic care involves bed rest while keeping the affected limb immobile. In this group, patients are angiographed all the time during study hours (6 hours) lying on their backs with flat head and flat feet, and placed a sandbag weighing approximately 3.5 kg on the arterial site to prevent bleeding. will be . During this time, patients can only bend and straighten their legs. In both groups, groin pain, patient comfort, hematoma, bleeding, leg pain, and urinary incontinence before and after sheet discharge were examined 6 times at one-hour intervals (8 times in total). Will take.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Providing research results to the subjects and officials of the research environment, if desired and requested, in accordance with the rights of the authors (according to paragraph 35 of the Helsinki Statement at the end of the study, participants have the right to be informed of the study results and the benefits of the results. Access to studies that have been found to be beneficial in terms of study or other appropriate care and benefits.

When:
Access available  6 months after printing results

To whom:
Providing research results to the subjects and officials of the research environment, if desired and requested, in accordance with the rights of the authors (according to paragraph 35 of the Helsinki Statement at the end of the study, participants have the right to be informed of the study results and the benefits of the results. Access to studies that have been found to be beneficial in terms of study or other appropriate care and benefits.

Conditions:
Providing research results to the subjects and officials of the research environment, if desired and requested, in accordance with the rights of the authors (according to paragraph 35 of the Helsinki Statement at the end of the study, participants have the right to be informed of the study results and the benefits of the results. Access to studies that have been found to be beneficial in terms of study or other appropriate care and benefits.

Where to obtain:
hojat niknam sarabi
offface92@gmail.com
09125574438

How to obtain:
Send email to the responsible author / Confirmation by other authors / Confirmation by Army University of Medical Sciences / Provide data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hojat Niknam Sarabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>in corner of Bahar Street, Taleghani Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15717</zip>
        <telephone>+98 21 8882 2222</telephone>
        <email>offface92@gmail.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hojjat Niknam Sarabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>502 Nazaja Hospital, in corner of Bahar Street, Taleghani Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15717</zip>
        <telephone>+98 21 8830 7020</telephone>
        <email>Offface92@gmail.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The satisfaction to participate in the study
Absence of hemophilia and coagulation disorders
The patient's age is between 45 and 70 years old
Femoral elective angiography candidate
Not treated with streptokinase
Routine use of half a promethazine ampoule and half a diazepam ampoule as a sedative
No history of low back pain</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient's unwillingness to continue to participate in the study
Complications such as bleeding, hematoma, and abnormal pain during the procedure
Painkillers or drugs before, during and after coronary angiography via the femoral</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: patients will be cared for in the first hour after angiography, lying down and keeping their legs still. In the second hour with a flat angle of 15 degrees, in the third hour they will be in a semi-sitting position with an angle of 30 degrees and in the fourth hour onwards with a 45 degree angle of the bed. It should be noted that at all stages of the intervention, the sandbag will be placed on the dressing area of ​​the arterial access site and the patients' feet will be flat. From the third hour onward, a pillow will be placed in the patient's lumbar region for more comfort. In case of bleeding, pain and dissatisfaction, the patient will return to the supine position and will be pressed 5 cm above the dressing area by hand. It remains and the routine treatment protocol continues. It is important to note that all patients prophylactically use anticoagulants such as aspirin 80 mg and Plavix 300 mg single dose for angiography as directed by their physician.</i_keyword>
      <i_keyword>Control group: In control group patients, routine post-angiographic care involves bed rest while keeping the affected limb immobile. In this group, patients are angiographed all the time during study hours (6 hours) lying on their backs with flat head and flat feet, and placed a sandbag weighing approximately 3.5 kg on the arterial site to prevent bleeding. will be . During this time, patients can only bend and straighten their legs. In both groups, groin pain, patient comfort, hematoma, bleeding, leg pain, and urinary incontinence before and after sheet discharge were examined 6 times at one-hour intervals (8 times in total). Will take.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Groin pain: groin pain refers to a feeling of discomfort in the area where the abdomen ends and the legs begin. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: Visual analog scale will be used to measure groin pain. Visual analog scale is used to measure pain. The visual analog scale of is the evaluation of pain intensity as a 10 cm horizontal line numbered from 0 to 10 (zero indicates the absence of pain and 10 indicates the most severe pain possible).</prim_outcome>
      <prim_outcome>Changing position: Fowler's condition is the patient's standard condition in which the patient is in a semi-sitting position (60-45 degrees) and the knees may be bent or straight. Fowler's position includes angles between 30 and 90 degrees. The upper Fowler represents a vertical position of about 90 degrees; the Fowler shows an angle of 45 to 60 degrees; the half Fowler, 30 to 45 degrees, and the lower Fowler, where the head is slightly elevated. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: In the intervention group,in the first hour after angiography, patients will be cared for lying down and keeping their legs still. In the second hour with a flat angle of 15 degrees, in the third hour they will be in a semi-sitting position with an angle of 30 degrees and in the fourth hour onwards with a 45 degree angle of the bed. It should be noted that at all stages of the intervention, the sandbag will be placed on the dressing area of the arterial access area and the patients' feet will be flat. The infection occurs. In this group, patients are angiographed all the time during study hours (6 hours) lying on their backs with flat head and flat feet, and placed a sandbag weighing approximately 3.5 kg on the arterial site to prevent bleeding. will be . During this time, patients can only bend and straighten their legs. In both groups, groin pain, patient comfort, hematoma, bleeding, leg pain, and urinary incontinence before and after sheet discharge were examined 6 times at one-hour intervals (8 times in total). Will take.</prim_outcome>
      <prim_outcome>Feeling comfortable: Comfort (feeling comfortable) is a feeling of physical or mental comfort, which is often characterized by a lack of difficulty. People who are uncomfortable experience discomfort. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: Visual scale was used to measure patient comfort. This visual scale is one of the tools developed by Colcaba Nursing Theorist to measure patient comfort. Studies show that visual scales are commonly used to measure mental perceptions such as pain and comfort. Patients were asked to rate their comfort according to the line and the numbers written.</prim_outcome>
      <prim_outcome>Hematoma: Localized bleeding outside the blood vessels, which occurs due to illness or trauma, including injury or surgery, and may lead to continued bleeding from broken capillaries. The hematoma is benign and initially spreads as fluid between tissues, including the interstitial sacs, which may coagulate and solidify in the blood vessels before reabsorption. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: The Christensen  scale will be used to measure hematoma.</prim_outcome>
      <prim_outcome>Leg pain: Prickle, cramping, fatigue and sometimes burning in the legs caused by poor blood circulation in the arteries of the legs. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: Visual analog scale will be used to measure leg pain. Visual analog scale is used to measure pain. The visual analog scale of is the evaluation of pain intensity as a 10 cm horizontal line numbered from 0 to 10 (zero indicates the absence of pain and 10 indicates the most severe pain possible).</prim_outcome>
      <prim_outcome>Urinary incontinence: Urinary retention is the inability to urinate. This complication is one of the main causes of benign prostatic , hyperplasia. Other causes of urinary retention include infections, neurological problems, constipation, and the effects of certain medications and amphetamines. This disorder of the urinary system means a small or incomplete emptying of the bladder. Sometimes the muscles of the bladder and bladder sphincter are not released and the urine is difficult to pass and causes the bladder to be completely emptied. Residual urine can lead to infection. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: We measure the severity of urinary retention based on visual scale and the duration of urinary retention in minutes, before and after the intervention. It should be noted that the severity of urinary retention in the postoperative stage was measured 10 minutes after the intervention, and given that there is no objective scale for measuring urinary retention, the patient's statements were used as a measure. The severity of urinary retention in patients after angiography was recorded in two time periods, including before the intervention and at the end of the intervention, based on the patient's personal statements, quantitatively through a scaled visual scale.</prim_outcome>
      <prim_outcome>Bleeding: Any bleeding that comes out of the circulatory system due to damage to the blood vessels is called bleeding. Bleeding may be due to vascular disorders, platelets, coagulation factors, coagulation inhibitors, exacerbation of fibrinolysis, or a combination of these factors. Typically, a healthy person can lose 10 to 15% of their total blood volume without serious medical problems. Tolerate. Timepoint: Before the intervention - after the intervention - the first / second / third / fourth / fifth  and  Sixth hours  after the intervention. Method of measurement: The amount of blood loss will be calculated based on the amount of bleeding based on the number of blood-soaked gases. Given that each 4 in 4 blood gasses in blood is about 10 ml of blood, then the amount of bleeding during 6 hours calculated  by multiplying the number of gases collected  in 10.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Artesh University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-21</approval_date>
        <contact_name>Ethics Committee of the AJA University of Medical Sciences is the medical school of Islamic Republic</contact_name>
        <contact_address>Tehran - West Fatemi St. - Shahid Etemadzadeh St. - Army University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
